Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury

T Hara, D Fukuda, K Tanaka, Y Higashikuni… - European Journal of …, 2018 - Elsevier
Accumulating evidence suggests that activated factor X (FXa), a key coagulation factor,
plays an important role in the development of vascular inflammation through activation of …

Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury

T Hara, D Fukuda, K Tanaka, Y Higashikuni… - European Journal of …, 2018 - infona.pl
Accumulating evidence suggests that activated factor X (FXa), a key coagulation factor,
plays an important role in the development of vascular inflammation through activation of …

Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury.

T Hara, D Fukuda, K Tanaka, Y Higashikuni… - European Journal of …, 2017 - europepmc.org
Accumulating evidence suggests that activated factor X (FXa), a key coagulation factor,
plays an important role in the development of vascular inflammation through activation of …

Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury

T Hara, D Fukuda, K Tanaka, Y Higashikuni… - European Journal of …, 2017 - cir.nii.ac.jp
抄録 Accumulating evidence suggests that activated factor X (FXa), a key coagulation factor,
plays an important role in the development of vascular inflammation through activation of …

Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury

T Hara, D Fukuda, K Tanaka… - European journal …, 2018 - pubmed.ncbi.nlm.nih.gov
Accumulating evidence suggests that activated factor X (FXa), a key coagulation factor,
plays an important role in the development of vascular inflammation through activation of …

[引用][C] Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury

T Hara, D Fukuda, K Tanaka, Y Higashikuni… - European Journal of …, 2018 - cir.nii.ac.jp
Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated
vascular injury | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …